title: [Assessment of visual function under treatment with topical antiglaucoma agents and systemic vasodilators. Clinical study on glaucoma patients].
abstract: The authors present some observations regarding the use of topical anti-glaucoma therapy and systemic vasodilators.
  
  
  METHODS
  The study was carried out on a series of 996 glaucoma patients, of which 54.1% with primary open-angle glaucoma, 5.7% closed-angle glaucoma, and 17.6% with normal intraocular pressure.
  
  
  RESULTS
  Intraocular pressure and visual field were assessed after the use of such therapeutic methods as carbonic anhydrase inhibitors (dorzolamide) and prostaglandin (latanoprost) and dorzolamide (cosopt) association.
  
  
  CONCLUSIONS
  The favorable progression of glaucoma could be improved by using new etiopathogenic mechanisms and treatment approaches.
authors.affiliation: Universităţii de Medicină şi Farmacie Gr. T. Popa Iaşi Universitatea de Medicină şi Farmacie Gr. T. Popa Iaşi Facultatea de Medicină.
authors.forename: S A
authors.initials: SA
authors.lastname: Popa
authors.forename: P M
authors.initials: PM
authors.lastname: Bucătariu
authors.forename: Doina
authors.initials: D
authors.lastname: Azoicăhi
authors.forename: D
authors.initials: D
authors.lastname: Costin
authors.forename: Alina
authors.initials: A
authors.lastname: Manole
authors.forename: Mioara
authors.initials: M
authors.lastname: Matei
authors.forename: Mihaela
authors.initials: M
authors.lastname: Merchez
mesh_terms: D000959:Antihypertensive Agents / Q000008:administration & dosage*; D002257:Carbonic Anhydrase Inhibitors / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D015812:Glaucoma, Angle-Closure / Q000188:drug therapy* / Q000503:physiopathology; D005902:Glaucoma, Open-Angle / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D000077338:Latanoprost; D009798:Ocular Hypertension / Q000188:drug therapy; D009883:Ophthalmic Solutions / Q000008:administration & dosage; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage*; D012189:Retrospective Studies; D013449:Sulfonamides / Q000008:administration & dosage*; D013876:Thiophenes / Q000008:administration & dosage*; D016896:Treatment Outcome; D014794:Visual Fields / Q000187:drug effects*
chemical_list: D000959:Antihypertensive Agents; D002257:Carbonic Anhydrase Inhibitors; D009883:Ophthalmic Solutions; D011461:Prostaglandins F, Synthetic; D013449:Sulfonamides; D013876:Thiophenes; D000077338:Latanoprost; C062765:dorzolamide